Tulane University Journal Publishing
Not a member yet
    2980 research outputs found

    Expatriation of Terrorists in the United Kingdom, United States, and France: Right or Wrong?

    Get PDF
    N/

    Sharing the Burden of Ebola Vaccine-Related Adverse Events

    Get PDF
    On December 9, 2014, United States Secretary of Health and Human Services SylviaBurwell issued a declaration under the U.S. Public Readiness and Emergency Preparedness (PREP)Act to provide immunity from legal claims related to manufacturing, testing, development,distribution, and administration of three candidate Ebola vaccines.1 At an earlier meeting of majorstakeholders held at the World Health Organization (WHO), the management of legal liabilitiesrelated to vaccines was an important subject of the global response to Ebola addressed by nationalgovernments, the World Bank, and others.2 That discussion, however, has faded as the epidemichas been brought under control even as clinical trials for vaccine candidates commence.3 ThisEssay argues that planning for the management of adverse event costs associated with rapidlydeveloped vaccines is in fact a critical opportunity in public health emergency preparedness andrecommends six options available to governments of countries afflicted by outbreaks of infectiousdisease, governments in countries where vaccines are likely to be developed, major global vaccinemanufacturers, and major third-party sponsors such as the Bill and Melinda Gates Foundation, theGlobal Alliance for Vaccines and Immunization (GAVI Alliance), the World Bank, and WHO

    Stichting Mothers of Srebrenica v. Netherlands : Does U.N. Immunity Trump the Right of Access to a Court?

    Get PDF
    N/

    Masthead

    No full text
    N/

    Will the Real Country of Origin Please Stand Up?

    Get PDF
    N/

    The Problem of “Double Remedies” in International Trade Disputes and the Economics of Pass-Through

    Get PDF
    In 2007, the United States reversed its long-standing policy prohibiting the simultaneousimposition of antidumping (AD) and countervailing duties (CVDs) against nonmarket economies(NMEs). Both the U.S. courts and the World Trade Organization have found the United StatesDepartment of Commerce’s (Commerce) continued use of its NME methodology in the ADinvestigation while simultaneously applying CVDs to offset domestic subsidies to violate domesticand international legal norms. The United States Congress recently changed U.S. law, authorizingsuch double remedies, but also called for an offset of the AD margin to reflect any duplicativeremedy for the same alleged unfairness. We review how this double remedies issue is addressedunder the new CVD legislation, how Commerce has addressed this issue in the past and isaddressing it now, and how the large body of economics literature on “pass-through” can shedhelpful light on these issues. Private parties making arguments to agencies, agencies makingdecisions, and tribunals reviewing these agency decisions will likely be struggling with these newissues for some time

    U.S. SEC v. Manterfield : How Her Majesty’s Courts Assisted the SEC in the Fight Against Global Financial Fraud

    Get PDF
    N/

    The Role of the Legal Adviser of the Ministry of Foreign Affairs: The Dutch Approach and Experience

    Get PDF
    N/

    2,413

    full texts

    2,980

    metadata records
    Updated in last 30 days.
    Tulane University Journal Publishing
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇